Orexigen (OREX), Arena (ARNA) Stronger into Qnexa PDUFA
Tweet Send to a Friend
Get Alerts OREX Hot Sheet
Up)
Trade OREX Now!
Orexigen Therapeutics (Nasdaq: OREX) is up again in early trading Monday. Shares have been volatile heading into the PDUFA date for peer VIVUS' (Nasdaq: VVUS) Qnexa obesity drug.
Volatility today is up 4.3 percent from last Friday's close.
Shares are 3.7 percent better at the start.
VIVUS PDUFA date is set for tomorrow, July 17th.
Both VIVUS and Arena Pharma (Nasdaq: ARNA) are also higher on the session so far.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Volatility today is up 4.3 percent from last Friday's close.
Shares are 3.7 percent better at the start.
VIVUS PDUFA date is set for tomorrow, July 17th.
Both VIVUS and Arena Pharma (Nasdaq: ARNA) are also higher on the session so far.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Amarin's (AMRN) Vascepa Not in FDA Orange Book for April
- Will Erickson Air-Crane (EAC) Stock Crash and Burn?
- Tableau Software (DATA) IPO Surges Higher
Create E-mail Alert Related Categories
FDA, Options, Trader Talk
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
